{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig377tzu527gkhgp3qejermfuzzewnugmfyis6sah3ezsw2wme3fi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhfcnenppbf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreighm6yjzaaplptng3ty35gflukp5i33mqw35ygkt6f5hibsuluyjm"
    },
    "mimeType": "image/jpeg",
    "size": 176887
  },
  "path": "/2026/03/18/azalea-therapeutics-signs-of-success-in-vivo-car-t-therapy/?utm_campaign=rss",
  "publishedAt": "2026-03-18T16:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "In the Lab",
    "biotechnology",
    "Cancer",
    "CRISPR",
    "research",
    "STAT+"
  ],
  "textContent": "A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access.",
  "title": "STAT+: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy",
  "updatedAt": "2026-03-18T06:04:53.000Z"
}